Perplexity vs Google DeepMind
Side-by-side trajectory, velocity, and editorial themes.
Perplexity pivoted from search API to agent platform with February's Agent API GA.
Perplexity now operates as a multi-surface developer platform: Search API, Agent API, Embeddings API, and a growing roster of third-party models routed through one OpenAI-compatible endpoint. The last six months added official Python and TypeScript SDKs, an MCP server, file attachments, and one-click integrations across Cursor, VS Code, Claude Desktop, n8n, and OpenClaw. Security and DX have matured in parallel — one-time-reveal keys, automated rotation, an interactive Search playground.
The center of gravity is shifting from search-augmented chat to autonomous agents that call tools, search the web, and reason over documents. Perplexity is also taking on a model-gateway role, exposing OpenAI, Anthropic, Google, NVIDIA, and xAI models behind its own /v1/agent endpoint. Distribution is moving from direct API integration toward embedded surfaces — MCP, n8n, AWS Marketplace — which lowers procurement and discovery friction for enterprise buyers.
Expect tighter agent-orchestration primitives next — handoffs, multi-tool plans, persistent memory — and an expansion of the Embeddings API into reranking. The AWS Marketplace listing suggests a deliberate enterprise sales motion is forming around the Agent + Search + Embeddings bundle.
DeepMind is repositioning Gemini as the substrate for scientific research, not just consumer AI.
DeepMind's recent output is dominated by Co-Scientist case studies and the formal launch of a 'Gemini for Science' suite, with applied research wins clustered around biology — aging, ALS, liver disease, infectious disease triggers. A second strand expands consumer-facing tools (Project Genie + Street View) for Google AI Ultra subscribers and pushes on content provenance. National partnership announcements (Singapore) round out the geopolitical surface.
The center of gravity is shifting from frontier model releases to vertical applications, particularly in life sciences. Co-Scientist appears to be moving from internal project to a packaged offering institutions can collaborate on. Consumer features and content authenticity work continue in parallel but feel secondary to the science push.
Expect a formal Co-Scientist productization announcement with institutional access tiers within the next quarter, and additional 'Gemini for X' verticals (likely materials science or drug discovery) to follow the science framing.
See more alternatives to Perplexity →
See more alternatives to Google DeepMind →